Oncolytics Pages on BioPortfolio:

BioPortfolio - Oncolytics
Therapeutics Daily: Jul 16 2008 1:12PM Matching: oncolytics biotech inc . ... Oncolytics patents - Entry on Bioportfolio's Biocorporate Database. ...
http://www.bioportfolio.com/search/Oncolytics.html...

BioPortfolio Oncolytics Profile
Oncolytics Biotech Inc Announces 2008 Second Quarter Results. KRON4 Jul 30 2008 637AM Matching ... KOTA Territory News Jul 30 2008 559AM Matching oncolytics ...
http://www.bioportfolio.com/biocorporate/7811-Oncolytics.pdf...

BioPortfolio Oncolytics Biotech Inc Profile
View the current Oncolytics Biotech Inc Page on BioPortfoliocom. httpwwwbioportfoliocombiocorporate27575Oncolytics+Biotech+Inchtml. Contact Details ...
http://www.bioportfolio.com/biocorporate/27575-Oncolytics+Bi...

BioPortfolio WellLife Healthcare Incorporated Profile
Oncolytics Biotech Inc Announces 2008 Second Quarter Results. KRON4 Jul 30 2008 637AM Matching well life healthcare. • Oncolytics Biotech Inc Announces 2008 ...
http://www.bioportfolio.com/biocorporate/10980-Well-Life+Hea...

Results from other life science and pharmaceutical sites:

BioSpace - Oncolytics Biotech Inc. News, Search Jobs, Events
Oncolytics Biotech Inc. 210-1167 Kensington Crescent Calgary Alberta T2N 1X7 Canada Phone: 403-670-7374 Fax: 403-283-0858 ...
http://www.biospace.com/company_profile.aspx?CompanyId=18710...

Oncolytics Biotech Inc. Starts Patient Enrolment in U.K. Phase II ...
Oncolytics Biotech Inc. Starts Patient Enrolment in UK Phase II Clinical Trial Investigating REOLYSIN(R) in Combination with Paclitaxel and Carboplatin.
http://biz.yahoo.com/cnw/080605/oncolytics_reolysin.html?.v=...

Oncolytics Biotech Inc. Treats 200th Cancer Patient in Clinical ...
Together with its collaborators, Oncolytics is now recruiting or enrolling patients in ten Phase I/II or Phase II clinical trials with REOLYSIN(R) in the ...
http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=109&STORY=...

Oncolytics Biotech Inc. Completes Dose Escalation in Combination ...
11 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. (Oncolytics) (TSX:ONC, NASDAQ:ONCY) has completed patient enrolment in the dose escalation portion of ...
http://biz.yahoo.com/prnews/080811/to752.html?.v=1...

Oncolytics Biotech Inc. Announces 2008 Second Quarter Results
"Oncolytics experienced a strong second quarter with the reporting of durable clinical responses to REOLYSIN(R) combination therapy treatment in refractory ...
http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=109&STORY=...

Oncolytics Biotech Inc. Completes Dose Escalation in Combination ...
11 Aug 2008 ... Oncolytics is a Calgary-based biotechnology company focused on the development of oncolytic viruses as potential cancer therapeutics. ...
http://www.biospace.com/news_story.aspx?NewsEntityId=106504...

Oncolytics Biotech Inc. Company Profile - Yahoo! Finance
Capsule info for Oncolytics Biotech Inc. ... Oncolytics Biotech is bringing in viral mercenaries to fight in the battle against cancer. ...
http://biz.yahoo.com/ic/116/116666.html...

Oncolytics Biotech Inc. Collaborators to Present Phase II Sarcoma ...
CALGARY, May 16 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. announced today that an abstract covering interim results of a Phase II study of ...
http://www.biospace.com/news_story.aspx?NewsEntityId=96926...

Oncolytics Biotech releases REOLYSIN phase I clini...[Expert Rev ...
Oncolytics Biotech releases REOLYSIN phase I clinical trial results. [No authors listed]. PMID: 12113234 [PubMed - indexed for MEDLINE] ...
http://www.ncbi.nlm.nih.gov/pubmed/12113234...

Home Marketing Services News Reports Company Profiles InDepth Drug Discovery Careers Conferences Videos Search Contact
	Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner. See User Agreement Send comments and feedback to: Peter Barfoot Managing Director, BioPortfolio Ltd. UK Tel: (+44) 1300 321501 USA Voicemail and Fax: (+1) 415 680 2472	All rights reserved. All other trademarks recognized. BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10 Copyright 1997-2008 - BioPortfolio Limited.